Prof. Thomas Levenson writes for The Boston Globe about the potential impact drug-resistant bacteria could have on the future of surgery. “As more and more bacteria show resistance to antibiotics, the risks change — to the point that doctors and patients alike may soon face agonizing choices about whether or when to take a chance on many of the surgeries we now accept as a matter of course,” says Levenson.
In an article for Popular Science, Kate Baggaley speaks with Prof. Timothy Lu and postdoc César de la Fuente about strategies they are developing to tackle antibiotic resistance. Lu explains that researchers are attempting to develop an arsenal of treatments to “be able to come at the problem from a variety of different ways.”
Angus Chen reports for NPR that MIT and Harvard researchers have captured footage showing bacteria invading antibiotics and transforming into superbugs. Postdoc Tami Lieberman explains that she hopes the visualization will help illustrate that “drug resistance is not some abstract threat. It's real."
Loren Grush of Popular Science writes about a new type of antibiotic developed by MIT researchers that could help kill drug-resistant bacteria. “[T]he team developed their own gene-editing system, capable of turning off certain bacterial genes that spur antibiotic resistance,” Grush explains.
A team led by Professor Timothy Lu has developed a new class of antibiotic that can selectively kill bacteria based on their genes, reports Michael Eyre for BBC News. "This is an enabling toolkit for the basic scientists to now start probing these systems a little bit better,” says Lu.
Researchers at MIT have developed a waterproof glue based on the proteins that allow shellfish to cling to rocks, reports Brooks Hays for UPI. "We're trying to figure out if by adding other mussel foot proteins, we can increase the adhesive strength even more and improve the material's robustness," said Professor Timothy Lu.
CBS News reports that MIT engineers have identified several combinations of genes that make bacteria more vulnerable to antibiotics. This research could help in the fight against “superbugs,” drug-resistant bacteria that kill at least 23,000 people per year in the U.S.